Emerald Health Therapeutics Inc.

account_balanceLife Sciences

  About Us
Emerald Health Therapeutics is a Health Canada Licensed Producer of medical cannabis. A vertically integrated, seed-to-sale enterprise, Emerald has combined core competencies from decades of experience in pharmaceutical innovation with large-scale agriculture expertise. Our ambition is to be at the forefront of developing knowledge and products that provide wellness and health benefits from cannabis.
Website

http://emeraldhealth.ca

http://emeraldhealth.ca

Headquarters

4420 West Saanich Road, Victoria, British Columbia V8Z 7E7

Public Issuance

2007

Shares Outstanding

136.85m

Corporate Filings

SEDAR

Stock Symbol

EMH:CA

location_on4420 West Saanich Road, Victoria, British Columbia V8Z 7E7
 3 Reasons to invest
  1. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility. Emerald has also entered into hemp chaff purchase agreements in 2018 and subsequent years.

  2. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility.

  3. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

If you are interested in investing in us, please join management, shareholders and other interested investors in our Investor Group. We want to ensure all investors are well informed and have access to important investor information.

Join Investor Group

+ Add Member
 Current Team
Thumb emerald health therapeutics image
X
Health Botanicals


With an industry-leading pool of cannabis genetics and a strong focus on product innovation backed by decades of rigorous pharmaceutical industry R&D and clinical development, Emerald is putting in place the components for creating consistent high-value downstream products for both the recreational and medical markets. We believe cannabinoid medicines present an unparalleled opportunity for use as therapeutic alternatives to a host of conventional pharmaceutical medicines that are typically much more toxic, potentially less efficacious, and often highly addictive. Emerald expects that proprietary intellectual property created through its product innovation efforts will be beneficial in creating competitive advantages as well as consumer confidence and product preference for a growing new wave of adult users.
add
Company offering default img
X
Offering Title

Offering Description

add
+ Add Publication
  Publications

Add Publication Title

Add Publication Description

+ Add Video
  Media
X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

X

Add Video Title

Add Video Description

chevron_leftchevron_right